Crescendo Health

Crescendo Health

Platform for real-world health data analysis

Overview

Crescendo Health collects and analyzes real-world health data to support medical research and product development. Its platform gathers data from insurers and medical providers through secure integrations with third-party vendors and APIs, serving healthcare professionals for informational and educational use. It differentiates itself by emphasizing real-world evidence, secure data integration, and collaboration with external data partners to deliver actionable insights. Its goal is to accelerate medical innovation by turning real-world data into insights that inform research, improve services, and guide feature development.

Significant Headcount Growth

About Crescendo Health

Simplify's Rating
Why Crescendo Health is rated
C
Rated C on Competitive Edge
Rated C on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

Healthcare

Company Size

11-50

Company Stage

Early VC

Total Funding

$3.4M

Headquarters

San Francisco, California

Founded

N/A

Get referred to Crescendo Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 2026 leadership expansion suggests active commercialization and customer-facing scientific support.
  • Updated sponsor pages emphasize HIPAA, Part 11, and GCP compliance for enterprise buyers.
  • Clinical research increasingly wants longitudinal real-world data, matching Crescendo's core product timing.

What critics are saying

  • No funding since January 2023 leaves 2026 growth dependent on sales execution.
  • Website-only proof and one CSO appointment signal limited market validation versus Datavant and Flatiron.
  • If sponsors balk at consent friction or data access delays, Crescendo's platform stalls.

What makes Crescendo Health unique

  • August 18, 2026 CSO hire David Strutton deepens Crescendo's RWE credibility.
  • Patient-consented longitudinal records from providers, payers, EHRs, and trials differentiate its dataset.
  • Crescendo pairs clinical research infrastructure with participant-accessible personal records, strengthening consent economics.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$3.4M

Above

Industry Average

Funded Over

1 Rounds

Early VC funding comparison data is currently unavailable. We're working to provide this information soon!
Early VC Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Parental Leave

401(k) Retirement Plan

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

15%

1 year growth

15%

2 year growth

15%
Associated Press
Aug 18th, 2026
Crescendo Health names David Strutton as chief scientific officer to advance clinical research data infrastructure

Crescendo Health has appointed David Strutton, PhD, as Chief Scientific Officer. Dr Strutton will lead the company's scientific strategy, evidence generation frameworks, and customer solutions aimed at advancing patient-centric clinical research. Dr Strutton brings decades of experience in clinical research, real-world evidence, and health economics. He previously held senior roles at Merck and Pfizer, where he established Merck's Center for Observational and Real-World Evidence and led Pfizer's Vaccines Global Health and Value division. At Crescendo Health, Dr Strutton will oversee the scientific rigour of the company's platform and partner with life sciences sponsors on evidence strategy and study design. Crescendo Health builds data infrastructure for clinical research, enabling secure, patient-consented access to health records and clinical trial data.

The Mirror Democrat and Savanna Times-Journal
Aug 18th, 2026
Crescendo Health appoints David Strutton, PhD as Chief Scientific Officer.

Crescendo Health appoints David Strutton, PhD as Chief Scientific Officer. * 2 hrs ago Crescendo Health, a leader in modernizing clinical research data infrastructure, today announced the appointment of David Strutton, PhD, as Chief Scientific Officer (CSO). In this role, Dr. Strutton will lead the company's scientific strategy, evidence generation frameworks, and customer solutions to advance patient-centric clinical research. Dr. Strutton brings decades of experience in clinical research, real-world evidence (RWE), and health economics, having led transformative scientific initiatives across the biopharmaceutical and digital health sectors including senior roles at Merck and Pfizer. Dr. Strutton played a pivotal role in establishing Merck's Center for Observational and Real-World Evidence (CORE) and spearheading integrated evidence strategies to support global access to Merck's innovations. At Pfizer, he led Vaccines Global Health and Value, delivering evidence to advance global access to vaccines, through work with national immunization technical advisory groups, including the CDC's Advisory Committee on Immunization Practice (ACIP). Cabinet ministers leave St James's Palace after Privy Council meeting Dr. Strutton is a Senior Fellow at The Center for the Evaluation of Value and Risk in Health (CEVR), part of the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center. Dr. Strutton holds a PhD from The Johns Hopkins University Bloomberg School of Public Health, where he also served as an adjunct faculty member for 20 years. "Dave's deep scientific rigor and long-standing leadership in observational research make him the ideal leader to advance our methodologies and support our customers in deploying them," said Sam Roosz, Co-Founder and CEO of Crescendo Health. "As clinical development increasingly relies on continuous, patient-consented real-world data, Dave's expertise will ensure our platform delivers the highest standard of scientific integrity to our sponsors, partners, and the patients we serve." At Crescendo Health, Dr. Strutton will oversee the scientific rigor of the Crescendo solution, partner with life sciences sponsors on evidence strategy and study design, and drive research demonstrating the utility of health data infrastructure in accelerating therapeutic development. "Crescendo Health is fundamentally changing how healthcare data is harnessed for scientific discovery by placing patients at the center of the research ecosystem," said Dr. Strutton. "I am thrilled to join the exceptional team at Crescendo to advance research methodologies that make clinical evidence generation more efficient, inclusive, and impactful." About Crescendo Health Crescendo Health builds data infrastructure designed to power the future of clinical research. By enabling secure, patient-consented access to comprehensive longitudinal health records, real-world data, and clinical trial endpoints, Crescendo Health helps life sciences organizations generate comprehensive evidence more quickly and efficiently. Crescendo Health works with leading biopharma, medical device, diagnostics, and CROs. For more information, visit www.crescendo.health. Media gallery

Business Wire
Jan 6th, 2023
Crescendo Health Launches to Improve and Accelerate Clinical Trials By Unlocking Patient Health Data

Crescendo Health, an innovative health data company powering the next generation of clinical research, today announced its official launch with a miss

Business Wire
Jan 5th, 2023
Crescendo Health Launches To Improve And Accelerate Clinical Trials By Unlocking Patient Health Data

SAN FRANCISCO--(BUSINESS WIRE)--Crescendo Health, an innovative health data company powering the next generation of clinical research, today announced its official launch with a mission to revolutionize how patients contribute real-world data to clinical studies. The company also announced an initial $3.4 million investment from leading early-stage investors, including Define Ventures as well as the founders and CEOs of many other well-known organizations.Founded by the co-founder of Datavant (merged with Ciox in a $7 billion deal), and a top product-management leader from Grand Rounds (merged with Doctor On Demand to form Included Health), Crescendo Health is a public benefit corporation that is unlocking access to traditionally siloed health data for both patients and clinical research sponsors. The company works with researchers from many types of healthcare organizations, including biopharma, medical device manufacturers and contract research organizations, to provide the tools and support required to collect and integrate information from patients' routine clinical care, helping them better understand long-term outcomes of new treatments.“Patients participating in clinical trials generate valuable health data throughout their healthcare journey, so researchers shouldn’t be limited to information gathered in the four walls of a research clinic. However, to date, these external real-world data elements weren’t accessible to trial sponsors at scale, which is why we’re building the machinery and support required to change the paradigm,” said Sam Roosz, co-founder and CEO of Crescendo Health. “We are working towards a future where research is seamlessly integrated with routine clinical care, making participation easy and accessible for patients from all backgrounds.”Led by a world-class team of former clinical research executives from institutions like Stanford and Medidata and seasoned digital product experts, Crescendo Health brings some of the most innovative digital health technologies that are transforming patient care to clinical trials, helping sponsors advance life-saving therapeutics in more efficient and cost-effective ways. The model works by garnering informed consent to collect health data on behalf of people participating in clinical research from any healthcare organization touching their care

Recently Posted Jobs

Sign up to get curated job recommendations

Crescendo Health is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →